May 29th

9:00 am – 11:00 am Dublin time

Auditorium 1

o Welcome and opening remarks – Relife & A.Menarini Pharmaceuticals Ireland

o Introduction – Prof. Desmond Tobin

Professor of Dermatological Science at UCD School of Medicine and Director of the Charles Institute of Dermatology.

o Optimal Management of Childhood Atopic Dermatitis in Primary Care – Prof. Alan Irvine
Consultant Dermatologist in Children’s Health Ireland (CHI) and at St James’s Hospital, Dublin and Professor of Dermatology in
Trinity College Dublin.

o Antioxidants and Eczema treatment: Evidence in action – Prof. Giovanni Pellacani

Chairman of Dermatology, University La Sapienza, Rome, Italy.

o Diaper Dermatitis Management - Targeting the 4 factors with a novel combination of topical agents – Prof. Adelaide Ann
Hebert
Chief of Paediatric Dermatology, UTHealth McGovern Medical School in Houston, Texas, USA.

o Q&A – Part 1

o Acne and Its Varying Presentations in a Pandemic – Prof. Nicola Ralph

Consultant Dermatologist Institute of Dermatologists, the Mater Private hospital and Blackrock Private Clinic. Clinical Assistant
Professor at University College Dublin.

o Key considerations for an innovative acne management programme – Prof. Giuseppe Micali
Head of Dermatology and Venereology, University of Catania, Catania, Italy.

o “A scaling tale“ Disorders of Keratinisation swiftly told – Dr. Lesley-Ann Murphy

Consultant Adult & Paediatric Dermatologist South Infirmary Victoria & Cork University Hospitals, Senior Clinical Lecturer
University College Cork.

o You really need to think about Urea: A century of clinical evidence dermatology – Prof. Giuseppe Micali
Head of Dermatology and Venereology, University of Catania, Catania, Italy.

o Q&A – Part 2

o Melasma & Hyperpigmentation key considerations and evidence to support novel agents – Prof. Desmond Tobin & Prof.
Enzo Berardesca
Prof. Desmond Tobin: Professor of Dermatological Science at UCD School of Medicine and Director of the Charles Institute of
Dermatology
Prof. Enzo Berardesca: Professor Phillip Frost Dept. of Dermatology, Miller School of Medicine, University of Miami, (USA)

o Closing remarks – Prof. Desmond Tobin

Organised by

IR-REL-87-2021 April 2021